PLEASANTON, Calif., Feb. 25, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.
On Wednesday, March 4, the company will participate in the Raymond James 36th Annual Institutional Investors Conference. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 8:40 a.m., Eastern Standard Time (5:40 a.m., Pacific Standard Time). A webcast of the presentation will be available at http://wsw.com/webcast/rj95/thor, or on the company's website at http://www.thoratec.com.
On Tuesday, March 10, Thoratec will participate in the Barclays Global Healthcare Conference. The presentation by Taylor C. Harris, Vice President and Chief Financial Officer, will begin at 2:50 p.m., Eastern Daylight Time (11:50 a.m., Pacific Daylight Time). A webcast of the presentation will be available at http://cc.talkpoint.com/barc002/031015a_ae/?entity=16_RX0VOBX, or on the company's website at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate II® and HeartMate III™ LVAS (Left Ventricular Assist Systems) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag®, PediMag®/PediVAS®, and HeartMate PHP™ product lines. HeartMate III is an investigational device and is limited by US law to investigational use. HeartMate PHP is currently in development and not approved for sale. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate, and HeartMate II are registered trademarks of Thoratec Corporation and HeartMate III, HeartMate PHP, and IVAD are trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.
SOURCE Thoratec Corporation